DAVID MAINA: Open Payments
NPI 1134746910 · ROSEDALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 8 payments from 5 companies in 2025. Trend: 2023 $48 · 2024 $121 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $150 |
| ABBVIE INC. | 3 | $82 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $15 |
Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
